Question and Answer

What is Faculty:Eric WombwellDuration:Approx.?

Faculty:Eric WombwellDuration:Approx. is Archive:.

How does Faculty:Eric WombwellDuration:Approx. Archive:?

Archive: Faculty:Eric WombwellDuration:Approx.

What is 6 HoursCopyright:Feb 15,?

6 HoursCopyright:Feb 15, is 2021 Description Dr. Eric Wombwell, PharmD, and Board Certified Infectious Disease Pharmacist will be your guide in this seminar, as you learn the latest evidence in the pharmacology of infectious diseases and application of this evidence to enhance your clinical pharmacy practice..

How does 6 HoursCopyright:Feb 15, will be?

6 HoursCopyright:Feb 15, 2021 Description Dr. Eric Wombwell, PharmD, and Board Certified Infectious Disease Pharmacist will be your guide in this seminar, as you learn the latest evidence in the pharmacology of infectious diseases and application of this evidence to enhance your clinical pharmacy practice.

What is new antibiotics,?

new antibiotics, is With vaccines, treatment guidelines, and evidence-based research continuously becoming available, the need to stay up-to-date is an imperative for pharmacists..

How does new antibiotics, continuously becoming?

With new antibiotics, vaccines, treatment guidelines, and evidence-based research continuously becoming available, the need to stay up-to-date is an imperative for pharmacists.

What is The CDC?

The CDC is recommends that pharmacists receive ongoing education about a variety of areas, including adverse reactions to antibiotics, antibiotic resistance and optimal prescribing.Dr..

How does The CDC recommends?

The CDC recommends that pharmacists receive ongoing education about a variety of areas, including adverse reactions to antibiotics, antibiotic resistance and optimal prescribing.Dr.

What is Wombwell?

Wombwell is will draw attention to clinical situations where antibiotics are overprescribed, unnecessarily used, and underutilized in the treatment of infections..

How does Wombwell will draw?

Wombwell will draw attention to clinical situations where antibiotics are overprescribed, unnecessarily used, and underutilized in the treatment of infections.

What is He?

He is will provide approaches to improve antibiotic use in these situations—resulting in reduced antibiotic cost, resistance, and collateral damage, improving patient outcomes in both outpatient and inpatient environments.You’ll leave with the knowledge and strategies to: Integrate current, best-practice treatment guidelinesLimit adverse reactions from antibioticsImplement antimicrobial de-escalation strategiesAnd more!Purchase this seminar, and as an added bonus, you’ll receive FREE access to the seminar Pharmacology of Pain Management for End-of-Life Care: Recommendations for Advanced Clinical Pharmacy Practice to build your knowledge about the pharmacology surrounding pain and comfort.The need for robust antibiotic stewardship has never been more pressing..

How does He will provide?

He will provide approaches to improve antibiotic use in these situations—resulting in reduced antibiotic cost, resistance, and collateral damage, improving patient outcomes in both outpatient and inpatient environments.You’ll leave with the knowledge and strategies to: Integrate current, best-practice treatment guidelinesLimit adverse reactions from antibioticsImplement antimicrobial de-escalation strategiesAnd more!Purchase this seminar, and as an added bonus, you’ll receive FREE access to the seminar Pharmacology of Pain Management for End-of-Life Care: Recommendations for Advanced Clinical Pharmacy Practice to build your knowledge about the pharmacology surrounding pain and comfort.The need for robust antibiotic stewardship has never been more pressing.

What is Purchase today!Please?

Purchase today!Please is click here to view hardware, software and internet connectivity requirements for this program..

How does Purchase today!Please click?

Purchase today!Please click here to view hardware, software and internet connectivity requirements for this program.

What is Considerations?

Considerations is Outline for Successful Empiric TherapySpectrum of activity for commonly used antibioticsNormal flora for infectious sitesResistance associated with common bacteriaPharmacodynamic influences on antibiotic dosingInterpretation of Microbiologic Test Results Gram stain resultsCulture and sensitivity resultsMinimum inhibitory concentration (MIC) evaluationPCR resultsAntibacterial ResistanceTrendsMechanisms of resistanceContributing factorsAntibiotic stewardship conceptsAntibiotic Related Allergies– Penicillin and ‘Sulfa’Define true allergy versus side effectPenicillin allergy and cephalosporin cross sensitivity ‘Sulfa’ allergySARS-CoV-2Clinical trial data for therapeuticsClinical trial data for vaccinesSkin and Soft Tissue InfectionsStreptococcus pyogenes vs..

How does Considerations Outline?

Outline Considerations for Successful Empiric TherapySpectrum of activity for commonly used antibioticsNormal flora for infectious sitesResistance associated with common bacteriaPharmacodynamic influences on antibiotic dosingInterpretation of Microbiologic Test Results Gram stain resultsCulture and sensitivity resultsMinimum inhibitory concentration (MIC) evaluationPCR resultsAntibacterial ResistanceTrendsMechanisms of resistanceContributing factorsAntibiotic stewardship conceptsAntibiotic Related Allergies– Penicillin and ‘Sulfa’Define true allergy versus side effectPenicillin allergy and cephalosporin cross sensitivity ‘Sulfa’ allergySARS-CoV-2Clinical trial data for therapeuticsClinical trial data for vaccinesSkin and Soft Tissue InfectionsStreptococcus pyogenes vs.

What is MRSAEvidence?

MRSAEvidence is for antibiotic managementIDSA treatment guidelinesVancomycin AUC/MIC monitoringPneumoniaEvidence for pathogen etiologyEvidence for antibiotic managementIDSA/ATS community-acquired pneumonia treatment guidelinesResistance risk factors and managementIDSA/ATS hospital- and ventilator-acquired pneumonia treatment guidelinesNew antibiotics for MDR infectionsInfluenzaEvidence on vaccine timing and use in older adultsClinical trial data for therapeuticsIDSA/CDC treatment guidelinesUrinary Tract InfectionsResistance trendsClinical trial data for therapeuticsAntibiotics for MDR infectionsClostridium Difficile InfectionRisk factor literature reviewCompare antibiotic risk levelsIDSA treatment guidelinesClinical trial data for therapeuticsProbiotics prophylaxis evidence review Faculty Eric Wombwell, PharmD, BCIDP Related seminars and products: 4 Eric Wombwell, PharmD, BCIDP, is a board certified infectious diseases pharmacist and Clinical Associate Professor for the Department of Pharmacy Practice and Administration at the University of Missouri - Kansas City, School of Pharmacy..

How does MRSAEvidence use?

MRSAEvidence for antibiotic managementIDSA treatment guidelinesVancomycin AUC/MIC monitoringPneumoniaEvidence for pathogen etiologyEvidence for antibiotic managementIDSA/ATS community-acquired pneumonia treatment guidelinesResistance risk factors and managementIDSA/ATS hospital- and ventilator-acquired pneumonia treatment guidelinesNew antibiotics for MDR infectionsInfluenzaEvidence on vaccine timing and use in older adultsClinical trial data for therapeuticsIDSA/CDC treatment guidelinesUrinary Tract InfectionsResistance trendsClinical trial data for therapeuticsAntibiotics for MDR infectionsClostridium Difficile InfectionRisk factor literature reviewCompare antibiotic risk levelsIDSA treatment guidelinesClinical trial data for therapeuticsProbiotics prophylaxis evidence review Faculty Eric Wombwell, PharmD, BCIDP Related seminars and products: 4 Eric Wombwell, PharmD, BCIDP, is a board certified infectious diseases pharmacist and Clinical Associate Professor for the Department of Pharmacy Practice and Administration at the University of Missouri - Kansas City, School of Pharmacy.

What is Wombwell?

Wombwell is is responsible for developing clinical and educational initiatives designed to optimize student learning..

How does Wombwell is?

Wombwell is responsible for developing clinical and educational initiatives designed to optimize student learning.

What is He?

He is is active in lecturing, research and hospital pharmacy practice.Dr..

How does He is?

He is active in lecturing, research and hospital pharmacy practice.Dr.

What is Wombwell?

Wombwell is completed his PharmD degree at the University of Missouri Kansas City, followed by an ASHP accredited pharmacy practice residency at the Kansas City VA Medical Center..

How does Wombwell completed?

Wombwell completed his PharmD degree at the University of Missouri Kansas City, followed by an ASHP accredited pharmacy practice residency at the Kansas City VA Medical Center.

What is residency completion,?

residency completion, is Upon Wombwell accepted a full-time non-tenured clinical faculty position at the University of Missouri - Kansas City, School of Pharmacy..

How does residency completion, accepted?

Upon residency completion, Wombwell accepted a full-time non-tenured clinical faculty position at the University of Missouri - Kansas City, School of Pharmacy.

What is His responsibilities?

His responsibilities is include teaching Doctor of Pharmacy students in a variety of courses, with special emphasis in the area of infectious diseases..

How does His responsibilities include?

His responsibilities include teaching Doctor of Pharmacy students in a variety of courses, with special emphasis in the area of infectious diseases.

What is part of this position,?

part of this position, is As Wombwell serves as a Clinical Pharmacy Specialist, working as part of the multidisciplinary team, providing care to acutely ill patients at Centerpoint Medical Center in Independence, Missouri..

How does part of this position, serves?

As part of this position, Wombwell serves as a Clinical Pharmacy Specialist, working as part of the multidisciplinary team, providing care to acutely ill patients at Centerpoint Medical Center in Independence, Missouri.

What is addition,?

addition, is In Wombwell functions in an adjunct faculty capacity with the University of Missouri - Kansas City, School of Dentistry, where he is responsible for teaching infectious diseases curricular content to dental students in the Pharmacology and Therapeutics course series.Dr..

How does addition, functions?

In addition, Wombwell functions in an adjunct faculty capacity with the University of Missouri - Kansas City, School of Dentistry, where he is responsible for teaching infectious diseases curricular content to dental students in the Pharmacology and Therapeutics course series.Dr.

What is Wombwell?

Wombwell is has more than 20 peer-reviewed publications on pharmacy and medication-related topics, and has delivered more than 50 invited presentations locally and nationally for continuing education to various health-professional audiences..

How does Wombwell has more?

Wombwell has more than 20 peer-reviewed publications on pharmacy and medication-related topics, and has delivered more than 50 invited presentations locally and nationally for continuing education to various health-professional audiences.

What is He?

He is has been named Teacher-of-the-Year in various capacities 7 times, "Missouri Pharmacist Association - UMKC Faculty Member of the Year" in 2016, and received the "UMKC Provost's Award for Excellence in Teaching" in 2014.Speaker Disclosures:Financial: Eric Wombwell is a Clinical Assistant Professor, Department of Pharmacy Practice at the University of Missouri – Kansas City..

How does He has been named?

He has been named Teacher-of-the-Year in various capacities 7 times, "Missouri Pharmacist Association - UMKC Faculty Member of the Year" in 2016, and received the "UMKC Provost's Award for Excellence in Teaching" in 2014.Speaker Disclosures:Financial: Eric Wombwell is a Clinical Assistant Professor, Department of Pharmacy Practice at the University of Missouri – Kansas City.

What is He?

He is receives a speaking honorarium from PESI, Inc.Non-financial: Eric Wombwell has no relevant nonfinancial relationships to disclose..

How does He receives?

He receives a speaking honorarium from PESI, Inc.Non-financial: Eric Wombwell has no relevant nonfinancial relationships to disclose.